{"version":"1.0","type":"link","title":"Exploring tyrosine kinase inhibitors for HER2-positive breast cancer: comprehensive review on a complete pharmacology-molecular mechanisms, safety profiles, and insights from preclinical and clinical studies.","author_name":"Suryawanshi MV 외","author_url":"https://prs-insight.online/author/Suryawanshi%20MV","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/79358","thumbnail_width":1200,"thumbnail_height":630}